Empiric antibiotic treatment for septic patients in the ICU
Empiric Antibiotic Treatment for Septic Patients in the Intensive Care Unit: Appropriateness and Therapeutic Outcomes
This study looks at how many ICU patients with sepsis get the right antibiotics quickly enough to see if it can help improve their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 155 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | Meir Medical Center Academic / other |
| Locations | 1 site (Kfar Saba) |
| Trial ID | NCT05924126 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients admitted to the intensive care unit (ICU) due to sepsis or septic shock. It aims to evaluate the proportion of these patients receiving appropriate empiric antibiotic therapy within the recommended timeframe. The study highlights the critical importance of timely antibiotic administration, as delays or inappropriate choices can significantly impact patient outcomes. By analyzing data from patients admitted between January 1, 2020, and December 31, 2020, the study seeks to identify gaps in treatment practices and improve adherence to clinical guidelines.
Who should consider this trial
Good fit: Ideal candidates for this study are patients admitted to the ICU with sepsis or septic shock.
Not a fit: Patients admitted to the ICU for non-infectious reasons will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the management of sepsis in ICU settings, potentially reducing morbidity and mortality rates.
How similar studies have performed: Previous studies have indicated that timely and appropriate antibiotic treatment can significantly improve outcomes in septic patients, suggesting that this approach is supported by existing evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients admitted to the general ICU due to sepsis or septic shock between 1/1/20 and 31/12/20 Exclusion Criteria: Patients who were admitted due to other non-infectious etiologies \-
Where this trial is running
Kfar Saba
- Meir Medical Center — Kfar Saba, Israel (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.